| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $499K | -83.3% |
| Cost of Revenue | $5.1M | -15.0% |
| Gross Profit | -$4.6M | -51.8% |
| R&D Expense | $7.4M | +8.4% |
| SG&A Expense | $14.4M | +25.0% |
| Operating Income | -$28.2M | -21.0% |
| Pre-tax Income | -$34.2M | -48.9% |
| Net Income | -$34.2M | -48.9% |
| EPS (Basic) | -$8.19 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.4M | -14.5% |
| Short-term Investments | $9.8M | +0.0% |
| Accounts Receivable | $219K | -57.1% |
| Inventory | $3.4M | +253.7% |
| Current Assets | $49.0M | -5.6% |
| Total Assets | $52.9M | -3.9% |
| Current Liabilities | $4.3M | +92.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.2M | -39.8% |
| Capital Expenditures | $2.1M | +34.9% |
| Investing Cash Flow | $8.9M | +178.5% |
| Financing Cash Flow | $21.6M | — |
| Free Cash Flow | -$28.3M | -39.4% |
| -1221.0% |
| EPS (Diluted) | -$8.19 | -65.5% |
| Total Liabilities |
| $27.5M |
| +839.1% |
| Stockholders' Equity | $14.1M | -72.8% |